HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

dofequidar (MS 209)

structure given in first source
Also Known As:
MS 209; MS-209
Networked: 16 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Tsuruo, Takashi: 4 articles (11/2009 - 02/2002)
2. Sato, Shigeo: 2 articles (11/2009 - 02/2002)
3. Koike, Sumie: 1 article (11/2009)
4. Fujita, Naoya: 1 article (11/2009)
5. Katayama, Ryohei: 1 article (11/2009)
6. Sugimoto, Yoshikazu: 1 article (11/2009)
7. Prous, J R: 1 article (06/2007)
8. Bayés, M: 1 article (06/2007)
9. Rabasseda, X: 1 article (06/2007)
10. Nomizu, Tadashi: 1 article (02/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Experimental Melanoma
3. Neoplasm Metastasis (Metastasis)
4. Small Cell Lung Carcinoma (Small Cell Lung Cancer)
5. Colorectal Neoplasms (Colorectal Cancer)

Related Drugs and Biologics

1. docetaxel (Taxotere)
2. quinoline
3. Paclitaxel (Taxol)
4. P-Glycoprotein
5. Doxorubicin (Adriamycin)
6. Vincristine (Oncovin)
7. Etoposide (VP 16)
8. Multidrug Resistance-Associated Proteins
9. Succinic Acid (Succinate)
10. Thrombomodulin

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Oral Administration
4. Stents